Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of oral sildenafil in pediatric pulmonary arterial hypertension after Study A1481131
2005-000963-25Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Pfizer. Primary endpoint: Safety parameters. Started Apr 2005; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2005-000963-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000963-25.